Approval · Notice of Compliance 35579 · 2025
LYSODREN: Notice of Compliance 35579
Issued June 26, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35579
- Date
- June 26, 2025
- Company
- Esteve Pharmaceuticals S.A.Barcelona, Barcelona, Spain
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Merger/Buy-out
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LYSODREN | 00463221 | Marketed |
Medicinal ingredients
- MITOTANE 500 MG per TAB